Delivery Order SPE2DB20D1100-SPE2DB24FC6J7

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The award, valued at $2,938.44, is a Firm Fixed Price contract with a completion date of July 2, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,418.90 to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. This order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and is valid through December 31, 2025. The IDC allows DLA to efficiently procure...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract is a Delivery Order valued at $1,932.28 with a firm fixed price and an ultimate completion date of May 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025,...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The Firm Fixed Price contract, valued at $2,570.12, has a completion date of May 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
The U.S. Defense Logistics Agency (DLA) awarded a $8,218.86 firm-fixed price delivery order to Amerisourcebergen Drug Corp, a division of pharmaceutical distributor Amerisourcebergen Corporation, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a $4,354.20 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This contract has an ultimate completion date of May 5, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA) under a Delivery Order valued at $3,308.04. The contract has a firm fixed price and an ultimate completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 0.75 mg/0.5 ml TRULICITY pens (0.5 ml). The $5,909.85 firm fixed price contract has a completion date of May 16, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a wide range of pharmaceutical products and medical supplies to support the Department of Defense. The company also...
The U.S. Defense Logistics Agency (DLA) awarded a $1,741.68 delivery order contract to Amerisourcebergen Drug Corp for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. This contract has a firm fixed price and an ultimate completion date of July 2, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award, valued at $2,228.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has a completion date of May 29, 2024 and is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC6J7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML medication. The contract, a Delivery Order valued at $2,731.69, has a firm fixed price and a completion date of July 10, 2024.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/8/24, 9:06 AM